Helio Genomics supported a Congressional briefing on liver cancer hosted by the American Liver Foundation at the Rayburn House Office Building in Washington, D.C.
Helio Genomics was proud to support a recent Congressional briefing on liver cancer hosted by the American Liver Foundation at the Rayburn House Office Building in Washington, D.C.
The briefing brought together leading medical experts, patient advocates, and policymakers to discuss the prevalence and risk factors of liver cancer, with a focus on communities at increased risk. Discussions also highlighted evidence-based strategies for prevention and treatment, as well as the importance of improving access to care.
As part of its ongoing collaboration with the American Liver Foundation, Helio Genomics supports initiatives that advance awareness, prevention, and policy efforts aimed at improving outcomes for patients affected by liver cancer. Helio offers a genomic test that supports the early detection of liver cancer, helping enable identification of disease at earlier stages, when intervention options may be broader and outcomes improved.
Through collaboration across science, advocacy, and public policy, the company is committed to advancing liver health and patient care. Helio Genomics thanks the American Liver Foundation for organizing this important briefing and looks forward to continued collaboration in advancing liver health.
Helio Genomics, in collaboration with the American Liver Foundation.